Skip to primary navigation Skip to main content
0 item $0.00

Preclinical Disease and Prevention

Reducing the risk of complications from cardiometabolic disease.

Read more

Laboratory head

Close
i Profile of author

Latest Achievements

European Society of Cardiology Heart Failure, Late breaking science award (2017)

European Society of Cardiology, Late breaking science award (2015)

European Society of Cardiology Heart Failure, Late breaking science award (2014)

American Heart Association, Late breaking trial (2014)

American Heart Association, Best research paper (2013)

Read full biography
Associate Professor Melinda Carrington Laboratory Head
Focused on supporting individuals to reduce their risk of complications from cardiometabolic disease.

Staff

Research staff

Ms Glynis Cacavas Ms Asmita Dalal Ms Carla Duarte Ms Batsheva Greenbaum Ms Sally Bronwyn Kay Ms Swetha Raghavan Ms Lilly Zhu

Postdoctoral Fellows

Dr Stephanie Yiallourou

 

About Preclinical Disease and Prevention

The Preclinical Disease and Prevention unit is devoted to helping people identify and address their risk of developing or managing two of Australia’s most prevalent chronic diseases — cardiovascular disease and diabetes. The research of the Preclinical Disease and Prevention unit is predominantly undertaken in community settings with a focus on higher risk individuals.

The Preclinical Disease and Prevention unit conducts rigorous, multi-disciplinary clinical trial research to demonstrate the benefits of nurse-facilitated models of care. Embedded within these disease management programs are the use of mobile devices (such as “apps” or avatars) and telehealth (phone or video conferencing) to promote health behaviour change and implement gold standard care to enhance management. Integral to this work is nurse management to deliver personalised care that targets risk and protective factors to help higher risk individuals.

We collaborate with eminent cardiologists, endocrinologists, leading GP academics and Aboriginal health researchers. These partnerships, combined with the Unit’s expert team of research fellows, clinical researchers, nurses and technical and administrative support staff enable the Unit to carry out innovative research for improving the management of cardiovascular disease.

Research focus

  • Randomised controlled trials of disease management programs for primary and secondary prevention of cardiometabolic disease.
  • Establishing the evidence for nurse-led models of care.
  • Risk detection and surveillance using a combination of traditional and novel risk indicators.
  • eHealth to achieve optimal patient care and outcomes.
  • Mass data analyses of primary care management of cardiometabolic risk.
  • Sleep.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more